Clinical Trial

Drug-Drug Interaction Study of Atumelnant in Healthy Participants

Name: Drug-Drug Interaction Study of Atumelnant in Healthy Participants — clinical trial record (NCT07570082)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the impact of strong CYP3A4 induction on the pharmacokinetics (PK) of atumelnant, as well as the effect of atumelnant on CYP3A4, P-gp, and MATE1/2-K substrates in healthy participants.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-07

Trial Details

NCT Number	NCT07570082
Lead Sponsor	Crinetics Pharmaceuticals Inc.
Conditions	Healthy Volunteers
Enrollment	46 participants
Start Date	2026-05-28
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-06